InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Get up to date on how experts are providing multidisciplinary care for patients with HR-positive/HER2-negative early-stage breast cancer at high risk of recurrence with downloadable slides and Medical Minute presentations adapted from a live workshop.

Share

Program Content

Activities

Adjuvant Therapy for HR+HER2- Early Breast Cancer
Selecting Adjuvant Therapy for Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Video
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2024

Expires: September 15, 2025

Activities

High Risk HRpos HER2neg EBC
InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2024

Expires: July 24, 2025

Faculty

cover img faculity

Tanya Gupta, MD

Palo Alto Medical Foundation
Palo Alto, California

cover img faculity

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Committee
Sarah Cannon Research Institute
Texas Oncology
Dallas, Texas

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Smart Patients

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Smart Patients

ProCE Banner